Tango Therapeutics (TNGX) Research & Development (2020 - 2026)
Tango Therapeutics' Research & Development came in at $37.2 million for Q2 2026, up 13.4% from $32.81 million a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Tango Therapeutics (TNGX) Research & Development (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tango Therapeutics reported Research & Development of $133.65 million, down 2.1% year-over-year; for FY2025, it came in at $132.17 million, down 8.2% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 21.5% (FY2020 to FY2025).
- Going back by year, Research & Development was $143.92 million in FY2024 (+24.9%), $115.2 million in FY2023 (+8.8%), $105.91 million in FY2022 (+36.4%) and $77.64 million in FY2021 (+55.3%).
- The Q2 2026 figure represents the highest quarterly Research & Development since Q2 2024.
- Year-over-year, Research & Development increased in three of the last eight quarters, with growth averaging 0.5%.
- The fastest year-over-year change in Research & Development over five years came in Q3 2021 (growth of 68.9%), and the weakest in Q2 2025 (a decline of 15.1%).
- Business Quant data shows TNGX's Research & Development at $33.53 million (Q1 2026), $32.1 million (Q4 2025) and $30.82 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Tango Therapeutics | 4.09 Bn | 2.20 Bn | - | 37.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.20 Mn |
| Mar 31, 2026 | 33.53 Mn |
| Dec 31, 2025 | 32.10 Mn |
| Sep 30, 2025 | 30.82 Mn |
| Jun 30, 2025 | 32.81 Mn |
| Mar 31, 2025 | 36.44 Mn |
| Dec 31, 2024 | 33.94 Mn |
| Sep 30, 2024 | 33.26 Mn |
| Jun 30, 2024 | 38.65 Mn |
| Mar 31, 2024 | 38.07 Mn |
| Dec 31, 2023 | 31.34 Mn |
| Sep 30, 2023 | 27.15 Mn |
| Jun 30, 2023 | 28.67 Mn |
| Mar 31, 2023 | 28.04 Mn |
| Dec 31, 2022 | 29.09 Mn |
| Sep 30, 2022 | 28.74 Mn |
| Jun 30, 2022 | 23.74 Mn |
| Mar 31, 2022 | 24.33 Mn |
| Dec 31, 2021 | 21.63 Mn |
| Sep 30, 2021 | 21.92 Mn |
API Access
Tango Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TNGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TNGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TNGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();